Steroid combo may improve tough lung fungus treatment
NCT ID NCT05444946
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at people with a mix of two lung conditions caused by the fungus Aspergillus: chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Researchers want to see if adding steroid pills to the standard antifungal drug itraconazole works better than itraconazole alone. About 104 adults will be randomly assigned to one of the two treatments and followed for a year to check if their symptoms and lung scans improve.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Itraconazole (oral antifungal) and prednisolone (oral steroid)
- What this could lead to
- If successful, this could establish a better treatment plan for people with both chronic and allergic aspergillosis, potentially improving symptoms and lung health.
- What could go wrong
- This is a small, early-stage trial with only 104 participants, so results may not apply to everyone. Adding steroids also carries risks like infection and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chest clinic
RECRUITINGChandigarh, Chandigarh, 160012, India
-
Chest clinic, PGIMER
ACTIVE_NOT_RECRUITINGChandigarh, 160012, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single injection tame severe asthma in fungal allergy?
- AI model aims to predict dangerous lung Flare-Ups in ABPA patients
- Fungal fingerprints in lungs may predict ABPA Flare-Ups
- New hope for rare lung infection: weekly drug shows promise in early trial
- Vitamin D's hidden role in TB and fungal lung disease revealed
- New study aims to improve inhaler treatment for lung fungus